Practical issues when confronting the patient who refuses blood transfusion therapy

American Journal of Clinical Pathology

Volumn 107, Issue 4 SUPPL. 1, 1997, Pages

  Bennett, Daniel R ^a,b   Shulman, Ira A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LAC USC MEDICAL CENTER   (United States)

Author keywords

Colloids; Crystalloids; Erythropoietin; Hemodilution; Jehovah's Witnesses; Perfluorocarbons; Salvaged blood

Indexed keywords

ERYTHROPOIETIN; FLUOROCARBON; HEMOSTATIC AGENT;

ALLERGIC REACTION; BLEEDING; BLOOD TRANSFUSION; COLLOID; CONSERVATIVE TREATMENT; CRYSTALLOID; ETHICS; HEMODILUTION; HEMOSTASIS; HUMAN; PATIENT ATTITUDE; PATIENT CARE; PRIORITY JOURNAL; RELIGION; REVIEW;

BLOOD SUBSTITUTES; BLOOD TRANSFUSION; CHRISTIANITY; COLLOIDS; CRYSTALLIZATION; ERYTHROPOIETIN; HEMODILUTION; HEMOSTATICS; HUMANS; LOS ANGELES; RELIGION; TREATMENT REFUSAL;

EID: 0030977818     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Rothenberg DM. The approach to the Jehovah's Witness patient. Anesth Clin North Am. 1990;8:589-607.
2. How Can Blood Save Your Life? The Watchtower Bible and Tract Society of New York, Inc. International Bible Senders Association, Brooklyn, New York; 1990:1-31.
3. Sacks DA, Koppes RH. Blood transfusion and Jehovah's Witnesses: medical and legal issues in obstetrics and gynecology. Am J Obstet Gynecol. 1986;154:483-486.
4. Kruskall MS. Alternatives to homologous transfusion. In: Anderson KC, Ness PM, eds. Scientific Basis of Transfusion Medicine: Implications for Clinical Practice. Philadelphia, Pa: WB Saunders; 1994:797-814.
5. Questions from readers. The Watchtower. June 1, 1990:30-31.
6. Physician's Desk Reference. 45th ed. Montuale, New Jersey: Medical Economics Company Inc; 1991:591.
7. Goldberg MA. Erythropoiesis, erythropoietin, and iron metabolism in elective surgery: preoperative strategies for avoiding allogeneic blood exposure. Am J Surg. 1995;170:37S-43S.
8. Nelson CL, Fontenot JH. Ten strategies to reduce blood loss in orthopedic surgery. Am J Surg. 1995;170:64S-68S.
9. Cooley DA. Conservation of blood during cardiovascular surgery. Am J Surg. 1995;170:53S-59S.
10. Law EJ, Still JM, Gattis CS. The use of erythropoietin in two burned patients who are Jehovah's Witnesses. Burns. 1991;17:75-77.
11. Kyo S, Omoto R, Hirashima K, et al. Effect of human recombinant erythropoietin on reduction of homologous blood transfusion in open-heart surgery: a Japanese multicenter study. Circulation. 1992;86:II-413-II-418.
12. American Medical Association. Drug Evaluations Annual 1995. Chicago, Ill: American Medical Assoc; 1995:2521-2523.
13. Questions from readers. The Watchtower. March 1, 1989:30-31.
14. Kruskall MS. Intraoperative autotransfusion. In: Rossi EC, Simon TL, Moss GS, eds. Principles of Transfusion Medicine. Baltimore, Md: Williams & Wilkins; 1991:411-417.
15. Dietz NM, Joyner MJ. Haemoglobin-based blood substitutes: what's on the horizon? Ann Acad Med Singapore. 1994;23(suppl):71S-76S.
16. Spence RK. Perfluorocarbons in the twenty-first century: clinical applications as transfusion alternatives. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology. 1995;23:367-380.
17. Hess JR, Winslow RM. Red cell substitutes. In: Anderson KC, Ness PM, eds. Scientific Basis of Transfusion Medicine: Implications for Clinical Practice. Philadelphia, Pa: WB Saunders; 1994:815-842.